Osteolabs

Executive Summary

Osteolabs is a UK-based diagnostics company addressing the critical need for early osteoporosis detection. With over 200 million people worldwide affected, osteoporosis often remains undiagnosed until fractures occur. Osteolabs' flagship product, OsteoTest, is a direct-to-consumer, at-home urine test that assesses individual risk and provides a comprehensive bone health report. This non-invasive approach democratizes bone health monitoring, enabling proactive management and reducing the burden of osteoporotic fractures.

Upcoming Catalysts (preview)

• Q3 2026CE marking or UKCA certification for OsteoTest75% success
• Q4 2026Publication of clinical validation study results60% success
• Q1 2027Strategic partnership with a major pharmacy or telehealth platform50% success